SCHEMBL8290926

SCHEMBL8290926

Cc1ncc(-c2ccccc2CN(C)C)cn1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 18/20 0.49
▸ CYP3A4 P08684 12/20 0.49
▸ ALDH1A1 P00352 9/20 0.49
▸ CYP2C19 P33261 7/20 0.49
▸ CLK4 Q9HAZ1 4/20 0.49
▸ CYP2D6 P10635 18/20 0.48
▸ HPGD P15428 3/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ HSD17B10 Q99714 6/20 0.46
▸ MAPT P10636 1/20 0.46
▸ TDP1 Q9NUW8 3/20 0.44
▸ ALOX15 P16050 2/20 0.44
▸ LMNA P02545 1/20 0.43
▸ HIF1A Q16665 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ATR Q13535 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8290925 0.83 CYP2D6 (0.49) CYP1A2CYP3A4ALDH1A1CYP2C19CLK4
SCHEMBL3464186 0.77 DPP4 (0.54) CYP1A2CYP3A4ALDH1A1CYP2C19CLK4
SCHEMBL9942304 0.77 FEN1 (0.44) CYP1A2CYP3A4CYP2D6MAPTSMN1; SMN2
SCHEMBL6772767 0.77 SLC6A4 (0.53) CYP1A2CYP3A4ALDH1A1CYP2C19CLK4
Bromide SCHEMBL27653706 0.76 DPP4 (0.52) CYP1A2CYP3A4ALDH1A1CYP2C19CLK4
Hydrochloric Acid SCHEMBL6048562 0.76 DPP4 (0.52) CYP1A2CYP3A4ALDH1A1CYP2C19CLK4
SCHEMBL17888364 0.75 KCNA5 (0.55) CYP1A2CYP3A4ALDH1A1CYP2C19CLK4
SCHEMBL743498 0.72 CYP1A2 (0.43) CYP1A2CYP3A4ALDH1A1CYP2C19CLK4
SCHEMBL6771225 0.72 CYP1A2 (0.47) CYP1A2CYP3A4ALDH1A1CYP2C19CLK4
SCHEMBL207285 0.71 GRM2 (0.45) CYP1A2CYP3A4ALDH1A1CYP2C19CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005032490-A2 CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-04-14 — — WO disclosed
Send feedback